October 25-26, 2022
Hero background

Event Session

Strategic Considerations for Life Sciences Claim Drafting

October 25, 2022 @ 12:15 PM EST

12:15 PM ET
October 25, 2022

Strategic Considerations for Life Sciences Claim Drafting

View Session Speakers

Over the past 80 years, about 40% of all FDA-approved pharmaceutical products have been in the form of pharmaceutical salts. The typical route for claiming such salts in patents involves claim cascades beginning with the ubiquitous “and pharmaceutically acceptable salts thereof” and often ends by naming the particular salt species of interest. Examples of such salts include sodium or hydrochloride salts of particular active pharmaceutical ingredients. There is room, however, to add an additional layer of claim coverage. Because salts can have solid-state structures, claim sets covering those structures may be constructed using the appropriate data. Moreover, and under the right circumstances, patents containing such claims may expire substantially after the expiration of the other corresponding salt patents.

More description to follow.



Add to Calendar 09/27/2022 2:22 PM America/New_York Strategic Considerations for Life Sciences Claim Drafting

Over the past 80 years, about 40% of all FDA-approved pharmaceutical products have been in the form of pharmaceutical salts. The typical route for claiming such salts in patents involves claim cascades beginning with the ubiquitous “and pharmaceutically acceptable salts thereof” and often ends by naming the particular salt species of interest. Examples of such salts include sodium or hydrochloride…

Session Speakers

Eyal Barash

Patent Attorney and Founder

Barash Law LLC

Debora Plehn-Dujowich

Debora Plehn-Dujowich

Member

Eckert Seamans Cherin & Mellott, LLC